Delivery Order SPE2DB22D2211-SPE2DB25FRNUG

Award Date 1/13/25
Potential Completion Date 2/4/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,883.70, is for the delivery of ALBUMIN (HUMAN) 5% IV SOLUTION 250ML, a medical supply. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 8, 2025. This award is not designated with a set-aside....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Albumin (Human) 25% IV Solution 50ML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,206.24, is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,109.70 for the supply of Albumin (Human) 5% IV Solution 250ML to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 18, 2024 and was awarded on June 26, 2024 as a Firm Fixed Price contract. Amerisourcebergen is a major pharmaceutical distribution company that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Albumin (Human) 5% IV Solution 250mL. The contract has a ceiling value of $3,642.00 and is a Firm Fixed Price Delivery Order with an ultimate completion date of August 29, 2024. This contract is not set aside for any specific socioeconomic program. Amerisourcebergen Drug Corp's Corporate Office Division is the...
This federal contract award, valued at $2,296.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567421581 - ALBUMIN (HUMAN) 5% IV SOLUTION 250ML, a critical medical commodity. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
The contract SPE2DX15D1022|SPE2DX24FVHXL was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,369.00 firm fixed-price delivery order is for the supply of Albumin (Human) 5% IV Solution 250ML, a critical medical product. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,034.46 firm fixed-price delivery order is for the supply of ALBUTEIN 25% IV Solution 100ML, a medical product. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,841.85, is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC enables the company to provide a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, involves the supply of a variety of pharmaceutical products and medical supplies to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $21,923.52 and is a delivery order, with a firm fixed-price pricing type. It does not have a set-aside designation. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies. The contract has a ceiling value of $15,152.80 and runs through July 2021. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRNUG
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Albumin (Human) 25% IV Solution 100mL to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $1,040.10 and is structured as a delivery order. It is not designated as a set-aside contract.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 4/14/25, 10:30 AM